drugset / Trial / NCT03976713
Bufei Yishen Granule for Reducing Acute Exacerbation in GOLD Stage 3 or 4 COPD
Phase 3
Unknown
348 enrolled
Henan University of Traditional Chinese Medicine
ShuGuang Hospital · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study aims to establish the treatment scheme of Bufei Yishen granule for GOLD stage 3 or 4 chronic obstructive pulmonary disease (COPD), reducing acute exacerbation, improving exercise capacity and forming high quality evidence.
Timeline
- Start
- 2019-06
- Primary completion
- 2020-06
- Completion
- 2020-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bufeiyishen granule | Traditional medicine (herbal / TCM) | — | Oral |
| Background | Tiotropium | Other / unclassified | 18 ug | Inhaled |